Food and Beverage News and Trends — April 2014: food industry opposes trans-fat bar and proposes setting limitations; and more
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.
Food industry opposes trans-fat bar, proposes setting limitations: Major food industry players recently urged the Food and Drug Administration (FDA) to consider alternatives to an outright ban on trans fats, including establishing an allowable level of trans fat and adjusting ‘rounding rules’ for listed trans-fat amounts. The food industry submitted more than 1,600 comments objecting to the FDA’s de-designation of partially hydrogenated oils (the major source of non-animal-derived trans fat in food) as GRAS, in part arguing that FDA lacks scientific support for its position.
FDA’s Hamburg: GE foods present no safety risks: At the 3/27/2014 House Budget subcommittee hearing on the fiscal year 2015 FDA budget, commissioner Hamburg reaffirmed the FDA’s stance on the voluntary labelling of GE foods and reiterated the FDA’s position that mandatory labelling is only necessary where there is a risk of misbranding or false labelling. She further stated that the FDA will soon re-assert that many credible scientific organisations analysing the issue have found no evidence of safety risks with GE foods and, from a safety perspective, the FDA does not believe GE modification would constitute a material change to the product…
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.